Thomas A. Mavrakanas
- Cardiology and Cardiovascular Medicine top 5%
- Internal Medicine top 2%
- Endocrinology, Diabetes and Metabolism top 5%
- Surgery
- Nephrology top 5%
- Co-authors
- David M. CharytanKarim GarianiHenri BounameauxCaroline SamerMark L. LipmanSharon J. NessimGershon FrischPierre‐Yves Martin
- Topics
- Atrial Fibrillation Management and Outcomes (23 papers)Diabetes Treatment and Management (17 papers)Heart Failure Treatment and Management (10 papers)
- Partner nations
- CanadaUnited StatesSwitzerland
In The Last Decade
Thomas A. Mavrakanas
66 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 87
- Cardiology and Cardiovascular Medicine 580
- Internal Medicine 253
- Endocrinology, Diabetes and Metabolism 208
- Surgery 170
- Nephrology 156
Countries citing papers authored by Thomas A. Mavrakanas
This map shows the geographic impact of Thomas A. Mavrakanas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Mavrakanas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Mavrakanas more than expected).
Fields of papers citing papers by Thomas A. Mavrakanas
This network shows the impact of papers produced by Thomas A. Mavrakanas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Mavrakanas. The network helps show where Thomas A. Mavrakanas may publish in the future.
Co-authorship network of co-authors of Thomas A. Mavrakanas
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Mavrakanas. A scholar is included among the top collaborators of Thomas A. Mavrakanas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Mavrakanas. Thomas A. Mavrakanas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 5 | |
| 7 | 5 | |
| 8 | 2 | |
| 9 | 4 | |
| 10 | 2 | |
| 11 | 14 | |
| 12 | 2 | |
| 13 | 9 | |
| 14 | 63 | |
| 15 | 13 | |
| 16 | 4 | |
| 17 | 22 | |
| 18 | 9 | |
| 19 | 26 | |
| 20 | 158 |
About Thomas A. Mavrakanas
Thomas A. Mavrakanas is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, having authored 77 papers that have together received 1.0k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (23 papers), Diabetes Treatment and Management (17 papers) and Heart Failure Treatment and Management (10 papers). The work is most often cited by research in Internal Medicine (253 citations), Cardiology and Cardiovascular Medicine (580 citations) and Nephrology (156 citations). Thomas A. Mavrakanas has collaborated with scholars based in Canada, United States and Switzerland. Frequent co-authors include David M. Charytan, Karim Gariani, Henri Bounameaux, Caroline Samer, Mark L. Lipman, Sharon J. Nessim, Gershon Frisch, Pierre‐Yves Martin, Katherine Garlo and Karandeep Singh. Their work appears in journals such as Diabetes Care, Stroke and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.